TORONTO, January 19 2021 – Alithya Group inc. (TSX: ALYA) (NASDAQ: ALYA) (“Alithya”), a leader in strategy and digital transformation, and a trusted supplier to the nuclear industry for more than 30 years, has partnered with the Canadian Nuclear Isotope
New study will strengthen opportunities for Canadian companies to expand their services and ensure the continued delivery of a reliable supply of life-saving medical isotopes. (TORONTO – December 22, 2020) – The Organization of Canadian Nuclear Industries (OCNI) and
Global leader in finding end-to-end solutions for transportation of radioactive materials becomes latest member of coalition of science, health care and nuclear sector advocating for life-saving medical isotopes TORONTO – December 21, 2020 – TAM International LP, a leader as
(TORONTO – November 26, 2020) – The Canadian Nuclear Isotope Council (CNIC), in partnership with the International Irradiation Association (IIA), has released a new report highlighting the economic, social and environmental benefits that arise from radiation processing around the world.
TORONTO – November 13, 2020 – Bucephalus Consulting, a thought leader in the world of nuclear power and an emerging thought leader on isotopes, has agreed to join the Canadian Nuclear Isotope Council to advance its advocacy and education agenda.
TORONTO – October 23, 2020 – Nuclear Science Week (NSW), which takes place October 19-23 this year, invites people from around the globe to “Get to Know Nuclear” and participate in a celebration that advances education, stimulates participation and generates
TORONTO – October 19, 2020 – Last week the strength of Canadian companies in the medical isotopes sector took another leap forward as Ontario Power Generation (OPG), its subsidiary Laurentis Energy Partners (Laurentis), BWXT ITG Canada Inc. and its affiliates
Isotopia Molecular Imaging and CPDC are pleased to announce that they have entered into an agreement for the production and distribution of no-carrier-added Lutetium-177 (n.c.a. Lu-177), a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for treatment of many
McMaster University to partner with CNIC and NII on major supply chain report
All across Canada, provincial leaders in the Health, Energy, Natural Resources and Research and Innovation portfolios are receiving an information package today from the Canadian Nuclear Isotope Council (CNIC) as it continues to push for a Pan-Canadian Strategy on isotopes.
On behalf of the Canadian Nuclear Isotope Council (CNIC), we would like to provide this submission to the Standing Committee on Finance & Economic Affairs regarding the government’s consultation on Bill 188, the Economic and Fiscal Update.
The Nuclear Innovation Institute (NII) and Canadian Nuclear Isotope Council (CNIC) have partnered on an innovative study to identify challenges and evaluate potential technology, logistical, regulatory and policy solutions in Canada’s medical isotope supply chain.